| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $216,665 | 1 | 2 |
Sells | $5,781,161 | 62 | 98 |
| MATLIN DAVID J | director | 1 | $216,665 | 0 | $0 | $216,665 |
| Ugwumba Chidozie | 10 percent owner | 0 | $0 | 62 | $5.78M | $-5.78M |
Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nanotechnology (CSN). CNM-Au8 stands as its flagship compound, currently under evaluation across a diverse range of clinical studies. This includes a pivotal Phase 2/3 study intended for regulatory submission in individuals battling amyotrophic lateral sclerosis (ALS). The company has successfully concluded a Phase 2 proof-of-concept trial for those …
Over the last 12 months, insiders at Clene Inc. have bought $216,665 and sold $5.78M worth of Clene Inc. stock.
On average, over the past 5 years, insiders at Clene Inc. have bought $4.92M and sold $1.85M worth of stock each year.
Highest buying activity among insiders over the last 12 months: MATLIN DAVID J (director) — $216,665.
The last purchase of 33,333 shares for transaction amount of $216,665 was made by MATLIN DAVID J (director) on 2026‑01‑13.
| 2026-05-12 | Sale | Ugwumba Chidozie | 10 percent owner | 73,296 0.6991% | $6.20 | $454,435 | -27.38% | |
| 2026-05-11 | Sale | Ugwumba Chidozie | 10 percent owner | 22,177 0.2303% | $6.75 | $149,695 | -25.31% | |
| 2026-05-04 | Sale | Ugwumba Chidozie | 10 percent owner | 72,884 0.6126% | $6.80 | $495,611 | -37.70% | |
| 2026-05-01 | Sale | Ugwumba Chidozie | 10 percent owner | 5,795 0.0567% | $6.01 | $34,828 | -16.94% | |
| 2026-04-30 | Sale | Ugwumba Chidozie | 10 percent owner | 5,736 0.0601% | $6.08 | $34,875 | -16.23% | |
| 2026-04-29 | Sale | Ugwumba Chidozie | 10 percent owner | 12,170 0.1181% | $5.63 | $68,517 | -10.78% | |
| 2026-04-28 | Sale | Ugwumba Chidozie | 10 percent owner | 1,591 0.016% | $5.90 | $9,387 | -11.28% | |
| 2026-04-21 | Sale | Ugwumba Chidozie | 10 percent owner | 61,345 0.596% | $6.14 | $376,658 | -16.06% | |
| 2026-04-20 | Sale | Ugwumba Chidozie | 10 percent owner | 4,318 0.043% | $6.12 | $26,426 | -13.33% | |
| 2026-04-17 | Sale | Ugwumba Chidozie | 10 percent owner | 25,040 0.2536% | $6.43 | $161,007 | -15.45% | |
| 2026-04-16 | Sale | Ugwumba Chidozie | 10 percent owner | 7,748 0.0781% | $6.40 | $49,587 | -15.91% | |
| 2026-04-15 | Sale | Ugwumba Chidozie | 10 percent owner | 6,374 0.065% | $6.48 | $41,304 | -15.59% | |
| 2026-04-02 | Sale | Ugwumba Chidozie | 10 percent owner | 24,925 0.2452% | $4.81 | $119,889 | +6.84% | |
| 2026-04-01 | Sale | Ugwumba Chidozie | 10 percent owner | 4,278 0.0435% | $4.97 | $21,262 | +11.66% | |
| 2026-03-31 | Sale | Ugwumba Chidozie | 10 percent owner | 67,991 0.673% | $4.88 | $331,796 | +10.65% | |
| 2026-03-30 | Sale | Ugwumba Chidozie | 10 percent owner | 15,536 0.1644% | $5.10 | $79,234 | +13.07% | |
| 2026-03-27 | Sale | Ugwumba Chidozie | 10 percent owner | 17,470 0.1762% | $4.75 | $82,983 | +15.07% | |
| 2026-03-26 | Sale | Ugwumba Chidozie | 10 percent owner | 5,319 0.0533% | $5.40 | $28,723 | 0.00% | |
| 2026-03-25 | Sale | Ugwumba Chidozie | 10 percent owner | 7,098 0.0712% | $5.50 | $39,039 | -1.64% | |
| 2026-03-24 | Sale | Ugwumba Chidozie | 10 percent owner | 5,492 0.0554% | $5.78 | $31,744 | -5.93% |
| MATLIN DAVID J | director | 477824 3.3616% | $1.8M | 23 | 0 | <0.0001% |
| Ugwumba Chidozie | 10 percent owner | 103417 0.7276% | $389,882.09 | 2 | 62 | <0.0001% |
| Mosca Alison | director | 3238375 22.783% | $12.21M | 4 | 0 | <0.0001% |
| Stevens John Henry | director | 800204 5.6297% | $3.02M | 3 | 0 | <0.0001% |
| Gay Jonathon | director | 105625 0.7431% | $398,206.25 | 3 | 0 | <0.0001% |
| Etherington Robert Dee | Chief Executive Officer | 40149 0.2825% | $151,361.73 | 2 | 1 | <0.0001% |
| Mortenson Mark | Chief Science Officer | 28949 0.2037% | $109,137.73 | 1 | 1 | <0.0001% |
$17,525,882 | 60 | 5.22% | $64.7M | |
$103,288,323 | 51 | 4.78% | $56.52M | |
Clene Inc. (CLNN) | $24,478,755 | 37 | -34.59% | $53.59M |
$115,646,156 | 35 | 16.45% | $54.05M | |
$390,510 | 22 | 17.68% | $58.22M |
| Increased Positions | 17 | +68% | 1M | +156.45% |
| Decreased Positions | 8 | -32% | 71,497 | -9.12% |
| New Positions | 5 | New | 1M | New |
| Sold Out Positions | 4 | Sold Out | 53,165 | Sold Out |
| Total Postitions | 34 | +36% | 2M | +147.33% |
| Scoggin Management Lp | $1,443.00 | 2.5% | 250,000 | +107,250 | +75.13% | 2025-09-30 |
| Vanguard Group Inc | $1,160.00 | 2.01% | 200,979 | +12,622 | +6.7% | 2025-09-30 |
| Geode Capital Management, Llc | $438.00 | 0.76% | 75,989 | +7,661 | +11.21% | 2025-09-30 |
| Lunt Capital Management, Inc. | $302.00 | 0.52% | 52,260 | +1,250 | +2.45% | 2025-09-30 |
| Parsons Capital Management Inc/Ri | $215.00 | 0.37% | 37,243 | +743 | +2.04% | 2025-09-30 |
| Renaissance Technologies Llc | $176.00 | 0.3% | 30,440 | +30,440 | New | 2025-09-30 |
| Marshall Wace, Llp | $131.00 | 0.23% | 22,709 | +22,709 | New | 2025-09-30 |
| Morgan Stanley | $115.00 | 0.2% | 19,914 | +1,858 | +10.29% | 2025-09-30 |
| Northern Trust Corp | $97.00 | 0.17% | 16,802 | +5,305 | +46.14% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $87.00 | 0.15% | 15,025 | 0 | 0% | 2025-09-30 |